What is the GeneSight® Psychotropic test?

GeneSight Psychotropic is a pharmacogenomic test that analyzes clinically important genetic variations that can affect a patient’s response to psychiatric medications. The test informs you about which medications may require dose adjustments, may be less likely to work, or may have an increased risk of side effects based on your patient’s genetic makeup.

How Much Does It Cost?
Kroger Prescription Plans is focused on improving the health and wellness of all its members. As part of your patient’s plan benefits, your patient may be eligible to receive the GeneSight Psychotropic test at no cost.
1
people have taken the GeneSight test
1
clinical studies published in peer-reviewed journals. GeneSight Psychotropic is the only psychiatric pharmacogenomic test backed by such extensive research.
Become a provider of the GeneSight test
If you're interested in more information on the GeneSight test, please email us at isrteam@genesight.com.

Largest Mental Health Pharmacogenomic RTC Published in the Journal of Psychiatric Research

How do you provide the GeneSight® test?
The GeneSight® test is administered in your office.

Step 1
A buccal swab is used to quickly collect a sample of your patient’s DNA. Just put the swabs in the prepaid FedEx envelope and send to our lab.

Step 2
Go to MyGeneSight.com to place the order.

Step 3
About 2 days after we receive the sample, you can access your patient’s personalized report on the secure GeneSight website.

Healthcare Provider Perspectives

See what happens when the GeneSight® test becomes part of a clinician’s practice.

The GUIDED Study: The GeneSight Test Works
Dr. Gus Alva believes this type of pharmacogenomic testing should be a standard of care.

James Greer, M.D.
 “I was immediately dumbstruck by what a difference GeneSight made in my ability to understand why patients had not gotten better.”

GUIDED Study: Improvement for Those Who Need It Most
“When using the GeneSight test to help patients, response, remission, and symptom improvement rates skyrocket.”